Our Teams

Barry Selick, PhD

Vice Chancellor, Business Development, Innovation and Partnerships
Innovation Ventures

Prior to joining UCSF, Barry was the CEO of Threshold Pharmaceuticals, a fully integrated oncology drug discovery/clinical development company that he led as CEO from its Series A financing through IPO to its eventual sale in 2017. He was also a Venture Partner at Sofinnova Ventures from June 2002 until July 2007. Prior to Threshold, Barry co-founded and was CEO and Chairman of Camitro, a venture capital backed drug discovery technology company with teams in California and Cambridge, UK, which was acquired 2 years after its founding. Before Camitro, Barry was at Affymax Research Institute, which was acquired by Glaxo Wellcome, plc as its drug discovery technology development center and where Barry was Vice President of Research, responsible for technology development and drug discovery. Prior to Affymax, Barry was at Protein Design Labs (PDL) and Anergen. As a bench scientist at PDL, he co-invented the technology underlying fully humanized antibody therapeutics and applied that to daclizumab (Zenapax), the first FDA-approved fully humanized antibody therapeutic, that was licensed to and commercialized by Roche for the prevention of kidney transplant rejection. This technology has contributed to more than 15 FDA approved therapeutics with cumulative revenues in excess of $200B. Throughout his career, Barry has been a member of the Boards of Directors of a dozen both early stage venture capital-backed as well as public biotech companies and Chairman and/or Lead Director of 9 of those.

 

With a BA in Biophysics and PhD in Biology from the University of Pennsylvania, Barry was a Damon Runyan-Walter Winchell Cancer Fund Fellow as well as a Senior Fellow of the American Cancer Society at UCSF.

Tabitha Sedino

Executive Assistant
Innovation Ventures

Tabitha is the Executive Assistant to the Office of the Executive Vice Chancellor & Provost Business Development, Innovation, and Partnerships at UCSF and brings over 23 years of administrative experience to the table. Tabitha began working for UC in 2002. She worked at UCLA 2002-2007/ 2008-2014, UCSF 2014-2015, UCSD 2015-2018, and has returned to UCSF. She has worked in patient care, supervisory and management positions, and has spent the last 10 years working as an Executive Assistant for department chairs in Anesthesiology and Surgery.

Originally from Los Angeles, California, Tabitha began working in the medical field in 1995 for a facial plastic surgeon/ENT in Culver City, CA. She then worked at Cedars Sinai Medical Care Foundation from 1999-2002 as an Administrative Assistant for up to 15 physicians in the fields of internal medicine, cardiology, dermatology, plastic surgery to name a few, and assisted with onboarding and training new staff. Tabitha has supervised administrative assistants, worked directly with C-level executives, faculty, residents, and medical students.

Peter Kotsonis, PhD

Director
Office of Strategic Alliances

Peter is PhD-neuroscientist and drug hunter with 14 years in the pharmaceutical industry, project leader and co-inventor of Ronopterin (VAS203) for traumatic brain injury currently in Phase III clinical development. Peter has experience in academic start-ups (VasosoPharm Biotech GmbH) and pharma settings (Novartis Ag and Dainippon Sumitomo Pharma Co, Ltd). He joined UCSF in 2013, and his responsibilities include driving new partner opportunities, developing novel partnering models, and programmatic support using alliance management “best practices” comparable to industry. 

Cammie Edwards, PhD

Associate Director
Office of Strategic Alliances

Cammie Edwards, PhD, Program and Alliance Management (ITA), provides a direct interface between UCSF teams and external collaboration partners. In that role, she works with both teams in establishing collaborative strategic plans, maintaining effective communication, promoting cross-functional activities, monitoring progress and developing risk mitigation strategies. Cammie joined UCSF as the Program Director for the Stephen and Nancy Grand Multiple Myeloma Translational Initiative (Grand MMTI) in 2011, where she provides strategic and operational oversight for the program. Prior to joining the Grand MMTI, Cammie worked for 10 years with DNA Bridges, Inc., a corporate development firm dedicated to helping life science companies advance their programs and products. In her role there, she assisted clients in raising funds (> $20 million in both private and federal funding), corporate positioning, business development and managing large contracts for clients. She worked successfully with both U.S. and international clients in a broad range of areas including cancer therapeutics, biologics, vaccines, biodefense and biomarker technologies. Dr. Edwards obtained her PhD from the University of California, Berkeley.

Yuxi Lin, PhD

Alliance Manager
Office of Strategic Alliances

Yuxi is an Alliances and Business Development Manager at the Office of Strategic Alliances, where she works on developing industry partnerships, research scouting, and business development at UCSF. Previously, Yuxi worked as an intern at Columbia University's tech transfer office, Columbia Technology Ventures. She received her Ph.D. in biomedical sciences from Columbia University focusing on metabolic disorders and did her postdoctoral research in neurobiology and gastroenterology at UCSF.

William Smith, PhD, JD, MPH

Alliance Manager
Office of Strategic Alliances

Meghan Zubradt, PhD

Alliance Manager
Office of Strategic Alliances

Meghan focuses on business development, management of large industry partnerships, and early-stage translational research scouting across UCSF. Notable industry partners in her current portfolio include AbbVie, BMS, Pfizer, and Celgene. Meghan has a PhD in Biomedical Sciences from UCSF, obtained in Jonathan Weissman’s lab.

Charles Hart

Director
Catalyst

Charles Hart is the director of the Catalyst program. From 2004 to 2017 he was at Threshold Pharmaceuticals and responsible for both in vitro and in vivo preclinical translational studies. He was also project leader for the global clinical development program for the hypoxia-targeted anticancer drug evofosfamide (TH-302), a partnership with Merck KGaA. Prior to joining Threshold, Charles was Senior Director of Biology at Galileo Pharmaceuticals (2001 to 2004), Director of Drug Discovery at Signature Bioscience (2000 to 2001), and a Research Unit Director at Affymax (1990 to 2000). Charles received his AB in cell biology from the University of California, Berkeley in 1977, an MS in developmental biology from Stanford University in 1980, a PhD in molecular biology and genetics from Yale University in 1987, and completed a postdoctoral fellowship at the University of Strasbourg, France in 1990.

Roopa Ramamoorthi, PhD

Program Director, Devices and Therapeutics
Catalyst

Roopa Ramamoorthi brings a diverse scientific background in drug development, bacteriology, biotechnology, and engineering. Prior to joining UCSF, Roopa was Associate Director Partnering and Scientific Affairs at BIO Ventures for Global Health, where her focus was putting together collaborations between academic, non profit and pharmaceutical organizations to accelerate the development of drugs, vaccines and diagnostics for Neglected Tropical Diseases, TB and Malaria for the WIPO Re:Search Consortium. She worked for Bayer in California for more than five years as a scientist and senior scientist in development of antibody and other biological therapeutics and evaluating and bringing in platform technologies and has experience in science and technology consulting with Strategic Perspectives.

Roopa received her Ph.D. in biochemical engineering from the California Institute of Technology (Caltech) and conducted postdoctoral research at the University of Washington and at MIT. She is a registered patent agent and holds a Project Management Professional (PMP) certification. Roopa grew up in India where she received her B.S. in chemical engineering from the Indian Institute of Technology in Mumbai.

Elodie Steffen

Program Coordinator
Catalyst

Elodie joins the Catalyst team as the new program coordinator. She transitioned to UCSF from UC Berkeley, where she worked as an academic advisor and program coordinator for the psychology department.

Joseph Wagner

Director, UC Drug Discovery Consortium
Catalyst

Dr. Wagner joins the UC-DDC after over 15 years in senior leadership roles in the biotechnology industry. He was the Chief Executive Officer of two publicly traded companies: OncoCyte, a company focused on the development of blood-based cancer diagnostics, and BriaCell Therapeutics, which focused on the development of a cell-based cancer immunotherapy. He also served as President and Chief Technology Officer of Cell Targeting, a regenerative medicine company spun out of the Sanford-Burnham Institute and as Vice President of Cell Therapy at Neuronyx, which focused on developing regenerative medicines. Before joining industry, Dr. Wagner was an Associate Professor at the Karolinska Institute. Dr. Wagner received his Ph.D. in Pharmacology from Duke University.  

Sunita Rajdev, PhD

Interim Executive Director
Office of Technology Management

Sunita collaborates with UCSF faculty and researchers in identification, evaluation, protection and commercialization of inventions arising from their research. In addition to managing a large portfolio of technologies from diverse scientific disciplines, Sunita also provides leadership support in helping build relationships with internal and external stakeholders, define new strategies to identify and develop UCSF’s intellectual property, co-negotiate master industry-sponsored research partnerships and commercialize UCSF’s technologies through strategic partnerships with existing or start-up companies.
 
Sunita brings an extensive background in life sciences including B.Sc. and M.Sc. in Pharmacology from the All India Institute of Medical Sciences in Delhi, India, and a Ph.D. in Pharmacology from the University of Pittsburgh followed by postdoctoral training at UCSF. Sunita's graduate and postgraduate research focused on the molecular mechanisms underlying cellular injury in the brain. She has a strong technical background in neuroscience, pharmacology, molecular and cell biology.


Sunita is excited about the role she plays in facilitating UCSF’s goal of translating cutting edge scientific discoveries into commercial products for patient care and public benefit.

Daniel Abel, JD

Patent Prosecution and Business Manager
Office of Technology Management

Dan joined the OTM in March 2006, and is currently responsible for managing patent prosecution, agreement compliance, government reporting, case finances, and the operating budget. Dan earned both his B.A. (Phi Beta Kappa) and J.D. degrees from the University of Florida.

Kristin Agopian, PhD

Senior Licensing Officer
Office of Technology Management

Kristin manages a portfolio of technologies and works with UCSF faculty and staff to develop and commercialize their inventions. She drafts and negotiates many agreements, including outgoing material transfer, confidentiality, inter-institutional, option and license agreements.

Kristin has been managing intellectual property for UCSF since August 2008. She was previously a Senior Analyst with Health Advances, a healthcare business strategy consulting firm. She was also a Christine Mirzayan Science & Technology Policy Fellow at the National Academies, where she worked on improvements to university-industry relationships. Kristin holds a Ph.D. in Virology from Harvard University and an A.B. in Molecular Biology from Princeton University. She has research experience in HIV pathogenesis, cell signaling, cell biology, mouse genetics and Drosophila development and speciation.

Kristin is excited about helping UCSF researchers succeed in translation of their cutting edge research into technologies that will advance health worldwide.

Gonzalo Barrera-Hernandez, PhD

Associate Director
Office of Technology Management

I joined UCSF in 2012, following 12 ½ years at the office of Innovation, Alliances & Services (IAS) (formerly known as the Office of Technology Transfer) at the UC Office of the President, where I was responsible for all IP management and technology licensing matters of a life-sciences portfolio of technologies from several UC campuses.  While at IAS I was also responsible for the first UC System Proof-of-Concept Fund, the UC System-Wide Technology Transfer Forum Program, the Technology Transfer Annual Report for the UC System, and for managing for the UC System the approval process for the acceptance of equity in licensing transactions.  Prior to joining UC, I worked in technology transfer for 2 years, on detail, at the NIH.

I received my Ph.D. in Biochemistry and Molecular Biology from the University of Calgary, Canada, where my research focused on gene regulation in Diabetes mellitus. My postdoctoral research at the NCI-NIH focused on the role of the thyroid hormone receptor in cell cycle regulation and on the mechanism controlling the switch from cell cycle regulation to differentiation.  I received a degree in Biological Sciences from the University of Buenos Aires, Argentina.

I am passionate about helping UCSF achieve its mission of advancing health worldwide through partnerships with industry, and by working closely with faculty to commercialize UCSF inventions.

Jon Brown, PhD

Licensing Associate
Office of Technology Management

Jon is a Licensing Associate at the Office of Technology Management where he supports the licensing efforts at UCSF. He received a Ph.D. in Chemistry from UCLA on the influence on cage environment on porous, catalytically active materials. After post-doctoral research and working as a Tech Transfer Fellow at Sandia National Laboratories, Jon worked as a Patent Agent at WSGR where he developed in-depth expertise in building intellectual property portfolios, counseled clients in due diligence matters, and collaborated with business, legal and scientific partners.

Darya Bubman, PhD

Licensing and Material Transfer Officer
Office of Technology Management

Darya joined the Office of Technology Management (OTM) in November 2011. Her responsibilities include technology management, licensing and outgoing material transfer agreements. Darya earned a B.A. degree in Biochemistry from Cornell University in Ithaca, N.Y. and a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences in New York City. She conducted her doctoral work in the laboratory of Dr. Ethel Cesarman, studying deregulation of cancer signaling pathways by the Kaposi’s sarcoma-associated herpesvirus (KSHV) in primary effusion lymphoma. Following her graduate studies, Darya became an AAAS Science and Technology Policy Fellow and worked at the U.S. State Department in the Intellectual Property Office on international issues related to biomedical IP, innovation, and technology transfer. Prior to joining the OTM, she worked as a Technology Partnerships Manager at the NASA Ames Research Center located at Moffett Field, CA. Darya has a strong background in virology, oncology, pharmacology and molecular biology.

Darya is passionate about working with UCSF faculty and staff to transfer novel UCSF biomedical technologies from bench to bedside.

Heather Carrico, MS

Business Analyst
Office of Technology Management

Heather joined the UCSF Office of Technology Management (OTM) in October 2013. She handles case and license agreement compliance, including analysis of license agreements for diligence and financial terms and interpretation, reporting and enforcement.

Prior to joining OTM, she was at Stanford University’s Office of Technology Management for eight years. Heather earned her MS degree from University of San Francisco and her BA from San Jose State University.

Danielle Casey Callaghan, BA

Patent Prosecution Analyst
Office of Technology Management

Danielle is primarily responsible for handling the intake of invention disclosures and compliance with federal and non-profit sponsor reporting obligations. Danielle also contributes to various projects for OTM, which she joined in May 2016.

Ying-Li Chen, MBA

Technology Marketing Manager
Office of Technology Management

Ying-Li joined UCSF Office of Technology Management (OTM) in September 2014. She manages technology marketing outreach including push and pull targeted marketing campaigns; and OTM's newsletters to increase public awareness of UCSF technologies. Ying-Li works closely with her team to establish and expand UCSF industry-academia partnership. As part of her role, she attends local or national conferences such as JP Morgan Healthcare, and BIO International Convention to actively build relationships with business development professionals. In addition, she supervises the OTM’s Technology Marketing Analyst Internship Program.
 
Prior to joining the OTM, she spent over three years at the Johns Hopkins University Office of Technology Transfer as a corporate relations associate. She led a group of marketing analyst interns to perform both pull and push marketing and helped establish and maintain a customized customer relations database specifically for technology transfer. She brought in several opportunities which culminated in large licensing deals. Ying-Li holds a MBA degree from Johns Hopkins University and a BS degree in Biomedical Sciences from Chang Gung University.

Saunders Ching, PhD

Licensing Associate
Office of Technology Management

As a member of the UCSF Office of Technology Management, Saunders helps manage the intellectual property of UCSF scientists across a wide variety of disciplines. He is dedicated to guiding innovative UCSF technologies from the laboratory to the market for the benefit of patients.

Saunders received his PhD in Genetics from UCLA, where he studied the molecular mechanisms that control embryonic adrenal development. After completing his PhD, he moved to UCSF, where he trained as a postdoctoral fellow in the laboratory of Dr. Ophir Klein. During his postdoc, he used knockout mouse models to investigate the genetic causes of reproductive organ defects.

Tanya Feldman, BA

Senior Patent Prosecution Analyst
Office of Technology Management

Tanya handles various aspects of patent prosecution, government reporting obligations, and monitoring annuities, as well as special projects to streamline the work of the Technology Management team and support the overall mission of the OTM. Prior to joining the office, Tanya spent more than a decade working with various non-profits and small businesses specializing in cultural exchange and education in an administrative and project support capacity.

David Fung, PhD

Senior Licensing Officer
Office of Technology Management

David manages intellectual property arising from research conducted at UCSF. He works with faculty and staff to evaluate new inventions and to develop appropriate IP strategies, with the goal of commercialization of the technology through licensing, whether to established companies or to new ventures.

David has more than ten years’ experience in academic technology transfer, first at Memorial Sloan-Kettering Cancer Center, and then at Yale University. Prior to that, he was with PricewaterhouseCoopers serving its biotech and tech clients. His Ph.D. is in biophysics from Harvard University, and he has master’s and bachelor’s degrees in physics from the University of Illinois, Urbana-Champaign and Stanford University respectively.

David is enthusiastic about working with faculty and other researchers to commercialize new technology for the benefit of the public.

Ellen Kats, PhD

Assistant Director, Licensing
Office of Technology Management

As an Assistant Director of Licensing, Ellen is responsible for technology evaluation and management, commercializing technologies through licensing, as well as helping negotiate intellectual property terms for collaboration and sponsored research agreements with commercial partners. Ellen created and has been running the OTM's technology analyst internship program since 2012.

Ellen has been managing intellectual property on behalf of UCSF since February 2007, when she initially joined the Office of Technology Management. Over these years, Ellen has managed a large invention portfolio, completed a wide range of partnering deals, and played critical roles in the formations of several UCSF start-ups. Ellen holds a Ph.D. in Biomedical Science from UC San Diego, as well as a B.A. in Molecular and Cellular Biology from UC Berkeley. Her scientific background is strongest in molecular and cellular biology, cancer biology, and human and yeast genetics.

Ellen is passionate about aiding UCSF faculty and staff in realizing the fullest commercial potential in their inventions, and helping UCSF achieve its mission of advancing health worldwide through strategic partnerships leading to successes in clinical development and health sciences.

Andreia Lee, PhD

Licensing Associate
Office of Technology Management

Andreia is a Licensing Associate at the Office of Technology Management where she supports the licensing efforts at UCSF. Andreia received her Ph.D. in Biological Sciences from Columbia University where she investigated a transcriptional mechanism that prevents retroviral expression in embryonic cells in Stephen Goff’s lab. During her time at Columbia University, she was also a fellow with the Columbia Technology Ventures office and became interested in translating technologies that arise from the bench into marketed products that can reach a wide audience. Andreia also has experience working in biotech and is interested in finding opportunities in which industry and academia can work synergistically in bringing technologies to market.

Todd Pazdera, PhD

Associate Director
Office of Technology Management

I have over 10 years in licensing and business development experience that includes building significant research collaboration and licensing partnerships between academia and the life sciences industry. I also have significant interest and experience in starting venture backed companies based on university technology.

I did my Ph.D. in Biological Sciences at Carnegie Mellon University in the lab of Jon Minden, studying the role of programmed cell death in Drosophila embryonic development. I also have a B.S. in Cell and Structural biology (with honors) from the University of Illinois where I did neuroscience research.

My roles at UCSF include licensing, facilitating UCSF based start ups, negotiation of IP language in collaboration agreements and MTA's, faculty engagement to learn about the commercial relevance of their research and to educate them on what makes a "good invention" and building new relationships with industry and early stage investors. My focus areas include diagnostic and therapeutics but I also work with some software and medical device technology.

Heather Pittman

Strategic Transactions Officer
Office of Technology Management

As the inaugural Strategic Transactions Officer, Heather is responsible for the negotiation of strategic partnering agreements for UCSF Innovation Ventures. She is focused on supporting those researchers, partners, and companies looking to engage in the UCSF research enterprise. Heather also advises on contractual intellectual property matters, analyzes and interprets research and intellectual property policies, and serves as a liaison on behalf of the Office of Technology Management.

Prior to arriving at UCSF in April 2018, Heather negotiated on behalf of UC Irvine, UC Berkeley and, most recently, UC Office of the President. Heather earned dual MBA-MA degrees from Claremont Graduate University, a member of the Claremont Colleges.

Priya Ramu, PhD

Licensing Associate
Office of Technology Management

Priya Ramu is a Licensing Associate in the Office of Technology Management at UCSF. She helps manage intellectual property developed at UCSF by carrying out patentability assessments of inventions, coordinating patent prosecution and licensing of a variety of technologies to commercial partners.

She joined the office in 2016 and prior to that, contributed to Technology Transfer at Oregon Health & Science University by negotiating industry-sponsored research agreements, collaboration agreements and materials transfer agreements. Priya obtained her Ph.D. from the lab of Alexander Mankin at the University of Illinois at Chicago, where she investigated the molecular mechanism of ribosome stalling which is implicated in resistance to antibiotics. Prior to her Ph.D., Priya worked in the drug discovery group at Astra Zeneca, focusing on validating drug targets for Tuberculosis. Priya is excited about working at the intersection of academia and industry, where she can contribute towards translation of discoveries made in the lab to diagnostic, therapeutic or other commercial products to improve global health.

Gemma Rooney, PhD

Licensing Officer
Office of Technology Management

As a Licensing Officer, Gemma is responsible for evaluating and managing new technologies, determining the patenting strategy, commercializing technologies through licensing and helping to negotiate the intellectual property terms in sponsored research agreements with industry partners. Gemma has been co-managing the OTM’s internship program since 2014, when she joined the OTM team.

Gemma holds a Ph.D. in Neuroscience and Stem Cell Biology from the National University of Ireland, Galway, and a B.Sc. in Neuroscience from University College Cork, Ireland. She received postdoctoral training from the University of California, San Francisco and the Mayo Clinic College of Medicine. Her research focused on neurological applications of stem cell therapies. Gemma became very interested in translating science concepts into products that could improve patient health outcomes. Thus, transitioning to the field of technology transfer was a natural next step in her career. Gemma is motivated to apply her scientific expertise to help basic researchers and clinicians to bring their ideas, concepts and products into active patient use.

Shikha Sharma, PhD

Licensing Officer
Office of Technology Management

I joined the Office of Technology Management in January 2013. I am a zealous business development professional, with a passion for science and immense respect for innovators. I am privileged to work closely with the UCSF community of students, scientists, clinicians. I manage a diverse and exciting intellectual property portfolio and catalyze the transfer of UCSF scientific developments to the public through licensing and partnerships.

I am responsible for managing a portfolio of intellectual property developed by UCSF researchers comprising of therapeutic, device, software and dHealth technologies. My activities comprise evaluating invention disclosures from the campus laboratories; conducting technology assessments from a commercial perspective; formulating and implementing licensing and intellectual property management strategies; marketing the technology to prospective licensees; coordinating the filing and prosecution of patent applications; negotiating and writing contractual agreements and licenses.

I hold a BS in Life Sciences (with Honors), M.S in Molecular Genetics (with Distinction) and Ph.D. in Cardiovascular Sciences (2011). I did my doctoral work on Angiopoietin ligands at the University of Leicester, UK, where I studied the molecular basis of Angiopoietin-Tie binding interaction using a combination of rational design and directed evolution. I like reading about latest scientific innovations and enjoy the uniqueness and challenges in the field of intellectual property and technology transfer.

Catherine Smith, PhD

Licensing Associate
Office of Technology Management

In her role as a Licensing Associate for UCSF’s Innovation Ventures, Cathy is responsible for managing the University’s diverse intellectual property disclosures and assisting in licensing transactions.  Cathy joined the office in early 2016 and is enthusiastic about aiding faculty and staff in translating their scientific discoveries for the public benefit through commercial partnerships.

Cathy did her PhD at Columbia University and a post-doctoral fellowship at Ludwig Cancer Research– both focused on understanding the DNA damage response through biochemical, genetic, and molecular biology approaches.

Kathleen Wilson-Edell, PhD

Licensing Officer
Office of Technology Management

Kathy joined the UCSF Office of Technology Management (OTM) in March of 2014. She works with UCSF faculty members to protect intellectual property arising from their research and negotiates licenses to these technologies with both startups and established companies.

Prior to joining OTM full-time, Kathy was a part-time Technology Analyst with UCSF OTM while completing her postdoctoral training at the Buck Institute for Research on Aging in Dr. Christopher Benz’s laboratory. Her postdoctoral research focused on the role of ribosomal proteins in breast cancer. She received her Ph.D. in Genetics from Yale University in Dr. David Stern’s laboratory, studying regulation of gene expression and cytoskeleton rearrangement by BRCA1-related proteins. Kathy’s A.B. is from Cornell University, where she was a Presidential Research Scholar.

Kathy is passionate about helping UCSF investigators move their discoveries from the laboratory to the public domain.

Stephanie Marrus, MBA, MA, BA

Director
Entrepreneurship Center

Stephanie Marrus is Director of the Entrepreneurship Center. Her mission is to help start companies from UCSF science and technology and to build the entrepreneurial ecosystem at the University. Since joining in 2012, she has developed a robust suite of programs that have contributed to a vibrant entrepreneurial community at UCSF. In addition to heading the Center, she teaches and mentors startups and is Senior Lecturer/Course Director for UCSF’s entrepreneurship classes.

During a 25-year plus business career, she has worked with over 1000 companies in science and technology based industries as member of the management team, business consultant or mentor. Many of these companies have their technological roots at Berkeley, Stanford, UCSF, MIT and Harvard. She has had roles as CEO, COO and VP Business Development for public and private venture capital backed companies, led partnering and M&A transactions, headed corporate development, strategy, marketing, communications and investor relations. Her sector experience is in information technology and life sciences/healthcare.

In addition to her business career, she served as Deputy Secretary of Economic Affairs for a Massachusetts governor leading economic development and business policy, She also chaired an environmental cleanup fund board and became the fund’s Executive Director. She was President of a medical research foundation and served on the Advisory Board of a social venture startup accelerator. She mentors entrepreneurs globally through the US State Department and other programs.

She has translated her business experience to the classroom and teaches experiential courses in entrepreneurship in Silicon Valley and globally. She has been affiliated with entrepreneurship programs at the University of California, Berkeley and Stanford University’s Technology Ventures Program. She has taught and presented at conferences in Europe, Latin America, the Middle East, Africa and Asia. She frequently presents to international groups at UCSF.

Her academic titles have included Senior Lecturer at UCSF, Adjunct Professor at UC Berkeley’s Center for Entrepreneurship in Technology, Entrepreneur-in-Residence at UC Berkeley’s Haas School of Business and Entrepreneur–in-Residence for the Global Entrepreneurial Marketing Course at Stanford, She is National Science Foundation Certified National Faculty for Innovation Corps (I-Corps), its highly successful training for entrepreneurs. She led the creation of Lean LaunchPad for life science/healthcare under an NSF grant, now taught nationally by the NIH. She has been a guest lecturer at Singularity University.

Her global titles have included Adjunct Professor, St. Petersburg State University Graduate School of Management, Russia; Entrepreneur-in-Residence, King Abdullah University of Science and Technology (KAUST), Jeddah, Saudi Arabia; faculty at the Moscow School of Management Skolkovo Startup Academy in Russia and in Silicon Valley. She attended the US Russia Bilateral Presidential Commission meeting on innovation in Moscow. She has been a guest speaker in Saudi Arabia under the sponsorship of Princess Sitah Bint Abdullah Al-Saud, daughter of King Abdullah; the US Consulate General and the Jeddah Chamber of Commerce, and taught at King Abdullah University of Science and Technology (KAUST). She has taught at Tsinghua University, Beijing, at ESADE Business School, Barcelona, in Argentina, Chile, Mexico Vietnam and Morocco. She taught for the Finnish Ministry of Foreign Affairs and the Vietnam Ministry of Science and Technology in Vietnam, presented to local and US officials at the US Embassy in Hanoi and keynoted the Peace through Entrepreneurship conference in Morocco.

She participates in the State Department’s International Speaker Program and led a panel at the Global Entrepreneurship Summit (GES 2016) in Silicon Valley.

Her views on entrepreneurship in emerging markets have been published in the Wall Street Journal, the Moscow News and AmericaEconomia. She has been interviewed by Russian television, the BBC and Argentine radio.

Leslie Martinez Vargas

Program Manager
Entrepreneurship Center

Leslie is the Program Manager for the Entrepreneurship Center at UCSF; she manages the full general operations of the Center. She joined the Center in 2013 as a marketing programs intern. Her goal is to inspire, educate and attract audiences from the UC community, life sciences and healthcare industry, and the business community.

Michael Blum, MD

Director
Center for Digital Health Innovation

Dr. Michael Blum is the Associate Vice Chancellor for Informatics and a cardiologist at UCSF. He specializes in the care of patients with coronary artery disease, congestive heart failure, valvular heart disease and preventative cardiology. He is dedicated to the early detection of heart disease and prevention through a heart-healthy lifestyle that includes diet, exercise and stress reduction. In addition, Dr. Blum applies his expertise in technology as the Chief Medical Information Officer at UCSF Medical Center. He led the enterprise wide implementation of APeX, UCSF's new electronic health record. He has a special research interest in clinical decision support technology, social media and collaborative workspaces and their impact on the quality, effectiveness, and cost of patient care. He also leads UCSF's Center for Digital Health Innovation.

Dr. Blum earned his medical degree from New York University School of Medicine. He completed an internship and residency in internal medicine, followed by a fellowship in cardiovascular medicine at Yale University School of Medicine. He is a fellow of the American College of Cardiology and a member of numerous professional organizations, including the American College of Cardiology, and Association of Medical Directors of Information Systems. He is the recipient of numerous honors and awards, such as the AMDIS Award for Excellence and Achievement in Advancement of Clinical Information Systems. Dr. Blum is a Clinical Professor of Medicine in the Division of Cardiology at UCSF.

Rachael Callcut, MD

Director of Data Science & Advanced Analytics
Center for Digital Health Innovation

Dr. Callcut is General Surgeon and Associate Professor of Surgery at San Francisco General Hospital and Trauma Hospital. She leads a NIH and DOD funded team of researchers focused on integration of biomedical big data and surgical data science into critical care for improved clinical decision support.

Mary Elizabeth Chalk

Business Development
Center for Digital Health Innovation

Mary Beth is responsible for business development, including the recent transaction with GE. She has 25 years of broad healthcare expertise in conceiving and completing deals in digital health, biopharma, behavioral health, disease management, wellness, health systems, pharmacy benefit management, and health plans. Prior to UCSF, she was a co-founder of a venture capital backed digital health coaching solution built from IP validated at Partners Healthcare. Mary Beth holds a BBA in marketing and a BFA in commercial design.

Ed Martin

Director, Technology
Center for Digital Health Innovation

Ed is a technologist with 20+ years of experience in software engineering with the last 5 years at UCSF focused on cloud-computing application solutions.  He has a B.S. in Computer Science from UC Davis and a M.Sc. in Healthcare Information Technology from Boston University.

Aaron Neinstein, MD

Assistant Clinical Professor
Center for Digital Health Innovation

Board-certified in Endocrinology, Clinical Informatics, and Internal Medicine, I see patients in the UCSF Endocrinology Faculty Practice and lead the design, development, and implementation of innovative digital health solutions. I have years of experience in optimizing the electronic health record to support high quality and high value care as well as creating a more user-friendly experience for physicians and patients. I believe that health information needs to be easier for patients and doctors to access, share, understand, and use collaboratively in day to day care. My first effort toward this vision was on the founding team of Tidepool, a non-profit, open-source cloud platform and modern apps for managing type 1 diabetes. I currently lead efforts to enable an interoperable digital health ecosystem as Clinical Director of the Cisco-UCSF Connected Health Interoperability Platform initiative.

Rhona Snyman

Chief Strategy Officer
Center for Digital Health Innovation

Rhona is the Chief Strategy Officer for UCSF’s Center for Digital Health Innovation, responsible for developing, communicating, executing, and sustaining CDHI’s strategic initiatives. Prior to joining CDHI, Rhona was responsible for overseeing product development and business strategy for UCSF School of Medicine IT, which included planning the early-stage adoption of innovation programs such as Telemedicine and SalesForce. Rhona earned an honors B.S. in Computer Science at UCC, Ireland.

Elizabeth Gress, MPA

Innovation Program Manager
Surgical Innovations Team

Elizabeth manages the Surgical Innovations program, playing a key role in goal-setting, strategic planning, and outreach. Working closely with faculty leadership, Liz oversees Surgical Innovations’ accelerator and seed funding program, organizes project teams, and coordinates with stakeholders across campus.

Hanmin Lee, MD

Professor
Surgical Innovations Team

Dr. Lee is a pediatric surgeon with research interests in the integration of emerging devices and technologies in medicine. As Clinical Director of Surgical Innovations, Dr. Lee is passionate about collaborating with multidisciplinary experts to solve clinical needs.

Shuvo Roy, PhD

Professor
Surgical Innovations Team

Shuvo Roy, PhD, is a bioengineer focusing on the development of medical devices to address unmet clinical needs through strong collaboration and a multidisciplinary approach.

Dr. Roy is a professor at the University of California, San Francisco in the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine, and is a faculty affiliate of the California Institute for Quantitative Biosciences (QB3). He is the director of the Biodesign Laboratory located on the Mission Bay campus. In addition, he serves as the Technical Director of The Kidney Project and is a founding member of the UCSF Pediatric Device Consortium. He has developed and currently teaches a course on medical devices, diagnostics, and therapeutics and regularly lectures on the medical device design process to UCSF graduate students and to national and international academic and industry audiences. He is the author of more than 100 publications and co-author of three book chapters, and holds multiple patents for device developments.

Before joining UCSF in 2008, Roy co-directed the BioMEMS Laboratory in the Department of Biomedical Engineering at Cleveland Clinic in Cleveland, Ohio, focusing on clinical applications of MEMS. In 1992 he earned a BS degree, magna cum laude, for triple majors in physics, mathematics, and computer science, from Mount Union College in Alliance, Ohio. In 1995, he earned an MS in electrical engineering and applied physics and, in 2001, he earned a PhD in electrical engineering and computer science, both from Case Western Reserve University in Cleveland, Ohio.

He is the recipient of a Top 40 under 40 award by Crain’s Cleveland Business in 1999 and the Clinical Translation Award at the 2nd Annual BioMEMS and Biomedical Nanotechnology World 2001 meeting. In 2003, Dr. Roy was selected as a recipient of the TR100, which features the world’s 100 Top Young Innovators as selected by Technology Review, the Massachusetts Institute of Technology’s Magazine of Innovation. In 2004, he was presented with a NASA Group Achievement Award for his work on harsh environment MEMS. In 2005, Dr. Roy was named as a Who’s Who in Biotechnology by Crain’s Cleveland Business. In 2005 and 2007, he was recognized as a Cleveland Clinic Innovator. In 2009, he was nominated for the Biotechnology Industry Organization's Biotech Humanitarian Award, which is given in recognition of an individual who has used biotechnology to unlock its potential to improve the earth. In 2012, he was presented the Rising Star Award by BayBio Pantheon, and in that same year, he received the Innovation Pathway 2.0 Award from the Food and Drug Administration (FDA). Most recently, he was recognized as a Fellow by the Applied Innovation Institute in 2013.

Ralph Gonzales, MD, MSPH

Chief Innovation Officer
Clinical Innovation Center

Dr. Ralph Gonzales is Associate Dean for Clinical Innovation and Chief Innovation Officer for UCSF Health. His research has played a significant role in national and global efforts to combat antimicrobial resistance by improving antibiotic prescribing practices - the body of which provides a successful roadmap for translating evidence into practice, policy and public health. Dr Gonzales’ research is multidisciplinary, patient-centered, and informed by relevant stakeholders and policy makers such as the CDC, NCQA, professional societies and community clinicians and patients. It represents the full spectrum of translational research - from practice guideline development, to implementation of innovative health care interventions, to conducting larger community-based trials to examine the comparative effectiveness of different health care interventions.
In addition, Dr. Gonzales is currently leading several project teams in designing, implementing and evaluating new ways to improve primary care-specialty care communication and care coordination, focusing on strategies that achieve the triple aim of improving quality, outcomes and decreasing costs. One includes the use of eReferrals and eConsults to streamline the referral and coordination process; another project is evaluating new team-based strategies to reduce unnecessary follow-up visits in specialty care.

Jessica Chao, MBA, PharmD

Director
Clinical Innovation Center

Jessica overseas day-to-day operations and leads CIC partnerships with industry and academia. Previously, she has led product design in various San Francisco startups as well as co-founded Healtho, a consumer health information company. She is also the co-founder of one of the largest health meetups in Seattle, the Seattle Health Innovators.

Jessica received her MBA from the Johns Hopkins Carey Business School in 2012 while she concurrently completed her Residency in Health System Pharmacy Administration at Johns Hopkins Medicine. She also holds a Doctorate in Pharmacy and BS in Biochemistry from the University of Washington. While in college, she attended the UW Academy, an early entrance program for young scholars to attend university at an early age.

Regis Kelly, PhD

Executive Director, QB3, Byers Family Distinguished Professor, UCSF
QB3

Dr. Regis Kelly, a longtime UCSF research neuroscientist and former executive vice-chancellor, directs QB3's entrepreneurship activities and cross-campus, multidisciplinary research initiatives. He co-founded QB3's affiliated venture fund Mission Bay Capital and its flagship incubator [email protected] Dr. Kelly has a special interest in the basic science of neurodegenerative and aging related disease, and therapies for these conditions.

Ioana Aanei, PhD

Entrepreneurship Program Manager
QB3

Dr. Ioana Aanei manages QB3 Startup in a Box, the institute's program to assist life science entrepreneurs with grantwriting and the legal aspects of incorporation. Dr. Aanei also oversees the QB3 Breadboard initiative, which partners with industry, creating virtual teams of university researchers to tackle cross-disciplinary research challenges. She earned a PhD in chemical biology from UCSF.

Agnes Buenaventura

Financial Analyst, QB3
QB3

Ms. Buenaventura handles financial transactions and campus interactions for the institute.

Nora Ke

Executive Assistant to the Director
QB3

Ms. Ke assists Dr. Kelly and provides general support to the QB3 team.

Kaspar Mossman, PhD

Communications & Marketing Director, QB3
QB3

Dr. Mossman manages communications and marketing for QB3 and the Rosenman Institute, including overall strategy and web, email, social, and print channels. He is the first point of contact for many QB3 clients and partners. He earned a PhD in biophysics from UC Berkeley.

Herminio Neto

Innovation Project Manager
QB3

Herminio Neto manages logistics and planning for QB3 and Rosenman Institute events.

Christine Winoto

Deputy Director, QB3, Founder and Director, Rosenman Institute, Partner, Medtech Venture Partners Fund I
QB3

Ms. Winoto manages operations and finance at QB3 and its medical device initiative, the Rosenman Institute, which she founded, along with its affiliated venture fund, Medtech Venture Partners. She directs all aspects of the Rosenman Institute including partnership, the Rosenman Fellows program, and the annual Rosenman Symposium.